Who is the manufacturer of Mitotane?

Mitotane/Mitotane is a drug used to treat adrenocortical cancer. Its main function is to inhibit the function of the adrenal cortex and reduce the secretion of adrenal hormones. Regarding the manufacturer of mitotane, the drug was originally developed and marketed by Bristol Myers Squibb and became an important treatment option in this field.

Over time, mitotane's patent expired and other pharmaceutical companies began to enter the market. Currently, there are many pharmaceutical companies producing and selling mitotane around the world, including some large pharmaceutical companies and biopharmaceutical companies. These companies typically offer mitotane in API and dosage form to meet the needs of different markets.

In China, the production and sales of mitotane have gradually attracted attention. As the demand for treatment of adrenocortical cancer increases, domestic pharmaceutical companies have begun to develop and produce mitotane to provide patients with more convenient treatment options. In this regard, some well-known pharmaceutical companies may obtain production licenses to ensure the quality and safety of their products. However, currently in the domestic market, there are no original drugs or generic drugs available for sale.

It should be noted that mitotane is a prescription drug and patients must follow their doctor's instructions when using it. Mitotane products from different manufacturers may have differences in formulas, dosages and excipients. Therefore, when changing brands or manufacturers, you should consult your doctor to ensure treatment effectiveness and safety.

In addition, due to the side effects and indications of mitotane, patients need to be monitored regularly during treatment to prevent potential toxic reactions. This is also one of the important reasons to choose regular pharmaceutical companies and reviewed drugs.

Reference materials:https://en.wikipedia.org/wiki/Mitotane